Matthew L. Posard - Director at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
HALO on Nasdaq
All Insider Reports
All Insider Reports

Matthew L. Posard - trading volume in the past year for Halozyme Therapeutics, Inc.

Holdings reported by Matthew L. Posard for Halozyme Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 69.9K $4.03M $57.70 Aug 14, 2024 Direct
Option to Purchase Common Stock 8.8K $122K $13.87 Apr 25, 2024 Direct Common Stock

Transactions reported by Matthew L. Posard for Halozyme Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.